Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect

The availability of new potent systemic therapies for urothelial carcinoma may change the way we use standard chemotherapy perioperatively. In particular, identifying which patients with muscle-invasive bladder cancer (MIBC) would benefit from adjuvant chemotherapy (AC) is compelling. From a multice...

詳細記述

保存先:
書誌詳細
出版年:Eur Urol
主要な著者: Pederzoli, Filippo, Bandini, Marco, Briganti, Alberto, Plimack, Elizabeth R., Niegisch, Günter, Yu, Evan Y., Bamias, Aristotelis, Agarwal, Neeraj, Sridhar, Srikala S., Sternberg, Cora N., Vaishampayan, Ulka N., Théodore, Christine, Rosenberg, Jonathan E., Harshman, Lauren C., Bellmunt, Joaquim, Galsky, Matthew D., Gallina, Andrea, Salonia, Andrea, Montorsi, Francesco, Necchi, Andrea
フォーマット: Artigo
言語:Inglês
出版事項: 2019
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6852645/
https://ncbi.nlm.nih.gov/pubmed/31303258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.06.032
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料